<DOC>
	<DOCNO>NCT00823303</DOCNO>
	<brief_summary>Secondary Hyperparathyroidism ( SHPT ) occur many patient kidney disease lead bone disease . Active form vitamin D , calcitriol paricalcitol , treat SHPT , may different effect blood calcium . This study randomize patient SHPT stage 3 4 CKD treatment calcitriol paricalcitol , monitor patient incidence high blood calcium , effectiveness SHPT treatment .</brief_summary>
	<brief_title>Paricalcitol Versus Calcitriol Efficacy Safety Stage 3/4 Chronic Kidney Disease ( CKD ) With Secondary Hyperparathyroidism ( SHPT )</brief_title>
	<detailed_description>General Design - Open label , active comparator , multicenter , parallel group , phase 4 study paricalcitol versus calcitriol suppression PTH stage 3 4 CKD patient SHPT . - Total study duration 26 week ( 1 week screening , 24 week active medication , 1 week follow . - Patients meet inclusion/exclusion criterion include baseline laboratory result randomize paricalcitol calcitriol , enter 24 week treatment phase . Visits , include safety efficacy laboratory test week 4 , 8 , 12 , 18 , 24 . A follow visit perform 1 week stop study medication .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Hyperparathyroidism , Secondary</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>Inclusion Criteria 1 . Age &gt; 18 ; Able give inform consent 2 . Chronic kidney disease , estimate GFR 15 60 ml/min use abbreviate MDRD equation 3. intact PTH ( iPTH ) &gt; 120 pg/ml baseline 4. albumin correct calcium &gt; 8.5 mg/dL &lt; 10.0 mg/dL baseline 5 . Phosphorus &lt; 4.6 mg/dL baseline 6 . If phosphorus binder ; change dose within 4 week prior screen Exclusion Criteria 1 . Receiving active form vitamin D within 4 week prior screen ( calcitriol , doxercalciferol ; paricalcitol ; alfacalcidol ) 2 . Receiving &gt; 50,000 IU per month ergocalciferol &gt; 1000 IU cholecalciferol per day within previous 30 day . 3. history primary HPT 4 . On prednisone &gt; 30 day within previous 6 month 5. receive bisphosphonates calcitonin within previous 12 month 6 . Nonelective hospitalization within previous 30 day . 7 . Expected initiate dialysis receive kidney transplant within next 6 mo . 8 . History renal organ transplant 9 . History parathyroidectomy previous diagnosis primary hyperparathyroidism 10 . Receiving cinacalcet within 4 week prior screen . 11 . An active drug/alcohol dependence abuse history 12 . History noncompliance visit medication preclude study compliance opinion investigator 13 . Pregnant , able become pregnant unwilling use birth control method consider reliable principal investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>PTH</keyword>
	<keyword>Active Vitamin D</keyword>
	<keyword>hypercalcemia</keyword>
	<keyword>Chronic Kidney Disease</keyword>
</DOC>